bf/NASDAQ:SAGE_icon.jpeg

COM:SAGERX

Sage Therapeutics

  • Stock

Last Close

6.44

31/10 20:00

Market Cap

371.93M

Beta: -

Volume Today

1.38M

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.sagerx.com/
  • ipo date

    Jul 18, 2014

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatmen...Show More

competitor of